NR3C2 and chronic kidney disease: Currently, the clinical drugs used to treat CKD and its complications include renin-angiotensin-aldosterone system (RAAS) drugs, hypoglycemic agents, mineralocorticoid receptor antagonists, and erythropoiesis-stimulating agents (Huang et al., 2023).